Advanced Melanoma: Optimizing ICI-Based Therapies
Released On
November 22, 2024
Expires On
November 21, 2025
Media Type
Internet
Completion Time
45 minutes
Specialty
Hematology-Oncology
Topic(s)
Oncology, Skin Cancer
| This activity is provided by |  |
This activity is supported by an educational grant from Bristol Myers Squibb.
Credit Available
- Physicians — maximum of 0.75 AMA PRA Category 1 Credit(s)™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
The intended audience for this activity is oncology and hematology-oncology physicians involved in the management of patients with melanoma.
Program Overview
Patients with advanced melanoma face rapid disease progression and require complex treatments. This educational program delves into the latest in immune checkpoint inhibitors (ICIs), which offer improved survival rates and new hope. Through updates on the latest data and real-world case studies, participants will learn to apply emerging evidence to personalized ICI-based treatment plans for BRAF-mutant and wild-type melanoma.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Evaluate the latest clinical research on ICI-based monotherapies and combination therapies in patients with advanced melanoma.
- Develop first-line treatment strategies for patients with advanced melanoma, including tailored plans for those with BRAF-mutant disease.
Faculty
Activity Chair: Hussein A. Tawbi, MD, PhD
Professor
Deputy Chair, Department of Melanoma Medical Oncology
Co-Director, Andrew M. McDougall Brain Metastasis Clinic & Program
Melanoma Medical Oncology | Investigational Cancer Therapeutics
UT MD Anderson Cancer Center
Houston, TX
Allison Betof Warner, MD, PhD
Assistant Professor of Medicine (Oncology)
Mark and Mary Stevens Endowed Scholar in Melanoma
Director, Melanoma Program
Director, Solid Tumor Cellular Therapy
Leader, Melanoma & Cutaneous Oncology Clinical Research Group
Stanford University School of Medicine
Stanford, CA
Accreditation Statement
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation
Physician Credit Designation Statement
Vindico Medical Education designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Relationship information is accurate at the time of content development.
- FACULTY
Hussein A. Tawbi, MD, PhD (Activity Chair)
Relevant Financial Disclosures
Consultant Details: Boxer Capital, BMS, Eisai, Genentech, Iovance, Jazz Pharmaceuticals, Karyopharm Therapeutics, Medicenna, Merck, Novartis
Speaker for Ineligible Company Details: AbbVie
Independent Research Contractor Details: BMS, Dragonfly Therapeutics, Eisai, EMD Serono, Genentech, GSK, Merck, Novartis, RAPT TherapeuticsAllison Betof Warner, MD, PhD (Faculty)
Relevant Financial Disclosures
Consultant Details: BluePath, BMS, Immatics, Instil Bio, IO Biotech, Iovance, Lyell, Merck, Novartis, PfizerPlanner/Reviewer
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education Staff
No relevant financial relationships to disclose.
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity.
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 2 of the 3 posttest questions correctly. If a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ certificate.
Certificates will be immediately available for download for the participant.
Course Viewing Requirements
Hardware/Software Requirements
This certified CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.
Supported Browsers (Desktop/Mobile)
Chrome 45+, Firefox 40+, Edge, Edge Chromium, Safari 8+, Opera 31+
Disclosure of Unlabeled Use
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement and Disclaimer
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by contacting our designated copyright agent (as outlined below). In your email, kindly provide the following details:
- Specify the copyrighted work you believe has been infringed upon.
- Share your name, address, telephone number, and, if available, your email address.
- Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
- Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you are either the copyright owner or have the authority to act on behalf of the copyright owner.
- Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
[email protected]
or call: 856-994-9400, ext. 614
Contact Information
For CME questions please contact: [email protected].